drugset / Trial / NCT02685345
A Study of DS-8500a in Japanese Subjects With Type 2 Diabetes Mellitus Receiving Sitagliptin
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The objectives of the study is to evaluate the efficacy and safety of DS-8500a compared with placebo in patients with type 2 diabetes mellitus (T2DM) receiving sitagliptin.
Timeline
- Start
- 2016-01
- Primary completion
- 2016-09
- Completion
- 2016-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | FIRUGLIPEL | Small molecule | 25 mg | Oral |
| Subject | FIRUGLIPEL | Small molecule | 75 mg | Oral |